These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 5067790

  • 1. Combination chemotherapy of Hodgkin's disease in private practice.
    Greenberg LH, Wong S, Richardson AP, Dollinger MR.
    JAMA; 1972 Jul 17; 221(3):261-3. PubMed ID: 5067790
    [No Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP, Young RC, Berard CW, DeVita VT.
    Arch Intern Med; 1973 Mar 17; 131(3):388-90. PubMed ID: 4569375
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Luce JK, Frei E, Gehan EA, Coltman CA, Talley R, Monto RW.
    Arch Intern Med; 1973 Mar 17; 131(3):391-5. PubMed ID: 4688037
    [No Abstract] [Full Text] [Related]

  • 4. The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Fairley GH.
    Ser Haematol; 1973 Mar 17; 6(2):196-201. PubMed ID: 4784374
    [No Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy of Hodgkin's disease.
    Nison DW, Aisenberg AC.
    Cancer; 1974 Jun 17; 33(6):1499-504. PubMed ID: 4834147
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M, Teillet F, Weisgerber C, Dana M, Jacquillat C, Bernard J.
    Rev Prat; 1974 Oct 11; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E.
    Arch Intern Med; 1973 Mar 11; 131(3):439-45. PubMed ID: 4739436
    [No Abstract] [Full Text] [Related]

  • 9. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E, Kende G, Many A, Ramot B.
    Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045
    [No Abstract] [Full Text] [Related]

  • 10. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F, Coltman CA.
    Arch Intern Med; 1973 Mar 01; 131(3):362-6. PubMed ID: 4688035
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Frei E, Luce JK, Gamble JF, Coltman CA, Constanzi JJ, Talley RW, Monto RW, Wilson HE, Hewlett JS, Delaney FC, Gehan EA.
    Ann Intern Med; 1973 Sep 01; 79(3):376-82. PubMed ID: 4748254
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
    Zelechowska JA, Madej G, Piemkowska F.
    Nowotwory; 1976 Sep 01; 26(3):163-70. PubMed ID: 980801
    [No Abstract] [Full Text] [Related]

  • 18. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M, Monfardini S, Beretta G, Fossati-Bellani F, Bonadonna G.
    Natl Cancer Inst Monogr; 1973 May 01; 36():403-20. PubMed ID: 4126720
    [No Abstract] [Full Text] [Related]

  • 19. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR, Jones SE, Bull JM, William LA, Rosenberg SA.
    Cancer; 1973 Jul 01; 32(1):52-60. PubMed ID: 4716784
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.